Science and Technology

The Science and Technology team at Infinity Pharmaceuticals drives the innovation behind the development of eganelisib by combining expertise in polymer sciences, intellectual property, advanced scientific research, and biology. This team collaboratively focuses on optimizing the drug's formulation, protecting intellectual property assets, advancing the understanding of its biological mechanisms, and ensuring successful clinical outcomes.